Stephen L. Houff, MD brings a unique combination of clinical expertise, healthcare leadership, and personal advocacy to the International Myeloma Foundation Board of Directors. A graduate of the University of Maryland School of Medicine, Dr. Houff practiced clinical medicine for over 15 years before transitioning to healthcare business leadership. He founded and served as CEO of Hospitalists Management Group, growing it into a national company with 1,000 clinicians serving 140 healthcare systems across 38 states. He has also held leadership positions spanning anesthesia, perioperative medicine, radiology, and intraoperative neuromonitoring.

In August 2022, Dr. Houff was diagnosed with multiple myeloma and underwent stem cell transplant. Now in deep remission, he is passionate about ensuring early access to myeloma specialists and bridging the gap between cutting-edge research and community healthcare settings. Dr. Houff sees his role on the IMF Board as an opportunity to serve as a conduit between research, education, advocacy, and strategic initiatives that advance the Foundation's mission. His voice as a physician, patient, and business leader adds invaluable insight to the Board's work in translating scientific progress into better outcomes for myeloma patients everywhere.